Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 472Brain Neoplasms 306Glioma 257Neoplasms 122Astrocytoma 88Carcinoma, Non-Small-Cell Lung 76Breast Neoplasms 70Neuroblastoma 65Central Nervous System Neoplasms 61Melanoma 58Recurrence 46Lung Neoplasms 45Pancreatic Neoplasms 41Oligodendroglioma 37Ovarian Neoplasms 36Colorectal Neoplasms 36Neoplasm Metastasis 33Sarcoma 32Medulloblastoma 28Stomach Neoplasms 27Gliosarcoma 27Lymphoma 25Prostatic Neoplasms 24Head and Neck Neoplasms 24Neurofibromatosis 1 23Rhabdomyosarcoma 21Neurofibroma, Plexiform 19Esophageal Neoplasms 19Diffuse Intrinsic Pontine Glioma 19Cholangiocarcinoma 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Hemorrhagic Stroke × CNS × Clear all
NCT05397106 2026-02-27

Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve

Integra LifeSciences Corporation

Active not recruiting
160 enrolled
CNS

Hemorrhagic Stroke, Brain Neoplasms, Hydrocephalus, Hydrocephalus, Normal Pressure, Pseudotumor Cerebri

Data powered by HemOnc (CC BY 4.0) Colophon âš¡